Triferic ferric pyrophosphate citrate regulatory update

FDA approved a powder packet presentation of Rockwell’s Triferic ferric pyrophosphate citrate as an iron maintenance therapy in patients with hemodialysis-dependent chronic kidney disease (CKD). Rockw...